Richard Fang

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression”.

De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.15.549149

N/A

0.124DataRank · unranked

1 citations

Raquel Buj, Hui Wang, Jiefei Wang, Aidan R. Cole, Apoorva Uboveja +11 more

ATM inhibition drives metabolic adaptation via induction of macropinocytosis

The Journal of Cell Biology(2022)10.1083/jcb.202007026

N/A

0DataRank · unranked

14 citations

Chi‐Wei Chen, Raquel Buj, Naveen Kumar Tangudu, Richard Fang, Kelly E. Leon +7 more

ATR promotes mTORC1 activity via de novo cholesterol synthesis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.27.564195

N/A

0DataRank · unranked

4 citations

Alexandra N. Grumet, Richard Fang, Raquel Buj, Aidan R. Cole, Apoorva Uboveja +13 more

De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0450

N/A

0DataRank · unranked

9 citations

Raquel Buj, Hui Wang, Jiefei Wang, Aidan R. Cole, Apoorva Uboveja +14 more

ATR promotes mTORC1 activity via de novo cholesterol synthesis

EMBO Reports(2025)10.1038/s44319-025-00451-3

N/A

0DataRank · unranked

2 citations

Alexandra N. Grumet, Richard Fang, Raquel Buj, Aidan R. Cole, Apoorva Uboveja +13 more